Concepedia

Veerabhadra R. Vulupala

VR

Statistics

Publications

4

Citations

117

H-Index

4

Active since

2023

Affiliations

Texas A&M University(Current)

Veerabhadra R. Vulupala is an author at Texas A&M University specializing in life sciences, viral proteases, and molecular biology.

ORCID

Publications per year

2023–2024

4

Publications

4

Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease

Yugendar R. Alugubelli, Jing Xiao, Kaustav Khatua et al. · Journal of Medicinal Chemistry · 2024 · 72 citations · Full text

, , +15

A Systematic Survey of Reversibly Covalent Dipeptidyl Inhibitors of the SARS-CoV-2 Main Protease

Zhi Geng, Sandeep Atla, Namir Shaabani et al. · Journal of Medicinal Chemistry · 2023 · 23 citations · Full text

, , +15

Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors

Kaustav Khatua, Yugendar R. Alugubelli, Kai S. Yang et al. · Antiviral Research · 2024 · 11 citations · Full text

, , +14

SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the Enzyme

Lauren R. Blankenship, Kai S. Yang, Veerabhadra R. Vulupala et al. · ACS Medicinal Chemistry Letters · 2024 · 11 citations · Full text

, , +16

1–4 of 4